FDA — authorised 15 February 2024
- Application: ANDA217087
- Marketing authorisation holder: LUPIN LTD
- Status: approved
FDA authorised Iron Glycinate on 15 February 2024
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA authorised it on 15 February 2024; FDA has authorised it.
LUPIN LTD holds the US marketing authorisation.